Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis

W Hu, Y Chen, C Dou, S Dong - Annals of the Rheumatic Diseases, 2021 - ard.bmj.com
Osteoarthritis (OA) is a degenerative joint disease in the elderly. Although OA has been
considered as primarily a disease of the articular cartilage, the participation of subchondral …

Flavonoids: classification, function, and molecular mechanisms involved in bone remodelling

P Ramesh, R Jagadeesan, S Sekaran… - Frontiers in …, 2021 - frontiersin.org
Flavonoids are polyphenolic compounds spotted in various fruits, vegetables, barks, tea
plants, and stems and many more natural commodities. They have a multitude of …

TNF-α and IL-6: the link between immune and bone system

T Wang, C He - Current drug targets, 2020 - ingentaconnect.com
Osteoimmunology is a new subject which focuses on the communication between the
immune and the skeletal systems. Both the immune system and bone communicate with …

[HTML][HTML] Pseurotin A inhibits osteoclastogenesis and prevents ovariectomized-induced bone loss by suppressing reactive oxygen species

K Chen, P Qiu, YU Yuan, L Zheng, J He, C Wang… - Theranostics, 2019 - ncbi.nlm.nih.gov
Rationale: Growing evidence indicates that intracellular reactive oxygen species (ROS)
accumulation is a critical factor in the development of osteoporosis by triggering osteoclast …

Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice

B Dankbar, M Fennen, D Brunert, S Hayer, S Frank… - Nature medicine, 2015 - nature.com
Myostatin (also known as growth and differentiation factor 8) is a secreted member of the
transforming growth factor-β (TGF-β) family that is mainly expressed in skeletal muscle …

Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade

JB Moon, JH Kim, K Kim, BU Youn, A Ko… - The Journal of …, 2012 - journals.aai.org
SHIP is an SH2-containing inositol-5-phosphatase expressed in hematopoietic cells. It
hydrolyzes the PI3K product PI (3, 4, 5) P 3 and blunts the PI3K-initiated signaling pathway …

Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts

ZH Lee, HH Kim - Biochemical and biophysical research communications, 2003 - Elsevier
Receptor activator of nuclear factor kappa B (RANK) is a tumor necrosis factor receptor
(TNFR) family protein that plays an important role in the regulation of bone and immune …

Sphingosine 1‐phosphate as a regulator of osteoclast differentiation and osteoclast–osteoblast coupling

J Ryu, HJ Kim, EJ Chang, H Huang, Y Banno… - The EMBO …, 2006 - embopress.org
Sphingosine 1‐phosphate (S1P), produced by sphingosine kinase (SPHK), acts both by
intracellular and extracellular modes. We evaluated the role of SPHK1 and S1P in …

Interferon-gamma-mediated osteoimmunology

M Tang, L Tian, G Luo, X Yu - Frontiers in immunology, 2018 - frontiersin.org
Osteoimmunology is the interdiscipline that focuses on the relationship between the skeletal
and immune systems. They are interconnected by shared signal pathways and cytokines …

Reactive oxygen species stimulates receptor activator of NF-κB ligand expression in osteoblast

X Bai, D Lu, A Liu, Z Zhang, X Li, Z Zou, W Zeng… - Journal of Biological …, 2005 - ASBMB
It has been established that reactive oxygen species (ROS) such as H 2 O 2 or superoxide
anion is involved in bone loss-related diseases by stimulating osteoclast differentiation and …